Gerstein Joins New National Consortium on Rare Inherited Skin Diseases

Mark Gerstein
October 15, 2026

Mark Gerstein, Albert L. Williams Professor of Biomedical Informatics and a professor of Molecular Biophysics & Biochemistry, is a co-investigator in a new national research consortium on rare inherited skin diseases. Yale School of Medicine co-leads the Consortium for Hereditary Epidermal Differentiation Disorders (CHEDD) with Northwestern University Feinberg School of Medicine. It is funded by a five-year NIH award and is part of the NIH Rare Diseases Clinical Research Network.

Epidermal differentiation disorders are a group of genetic skin conditions, formerly known as ichthyoses and palmoplantar keratodermas. The consortium will build a patient registry and natural-history study, run a clinical trial of the targeted therapy erlotinib, and map the molecular changes behind each disorder to identify biomarkers of disease activity and treatment response. Gerstein will help lead that third project with Keith Choate, chair of Dermatology at Yale, directing biomarker data analysis and integration.

Read the full story at Yale School of Medicine →